TipRanks
Advertisement
Advertisement

CHGCF Stock Latest News

Chugai Takes Back Rights to Emugrobart as Roche Exits Obesity Program, Revives SMA Focus
Company AnnouncementsChugai Takes Back Rights to Emugrobart as Roche Exits Obesity Program, Revives SMA Focus
4d ago
Crovalimab Trial Completion Signals New PNH Opportunity for Chugai Investors
PremiumCompany Announcements
Crovalimab Trial Completion Signals New PNH Opportunity for Chugai Investors
1M ago
CHGCF
AQUA07: Chugai’s New ALK Lung Cancer Bet Moves Forward in Early Clinical Testing
PremiumCompany Announcements
AQUA07: Chugai’s New ALK Lung Cancer Bet Moves Forward in Early Clinical Testing
1M ago
CHGCF
Chugai’s SPYK04 Trial Completion: What It Means for CHGCF Investors
PremiumCompany Announcements
Chugai’s SPYK04 Trial Completion: What It Means for CHGCF Investors
2M ago
CHGCF
Chugai Pharmaceutical Earnings Call Highlights Growth Momentum
PremiumCompany Announcements
Chugai Pharmaceutical Earnings Call Highlights Growth Momentum
2M ago
Chugai Highlights FX Impact in Interim 2026 Financial Materials
PremiumCompany AnnouncementsChugai Highlights FX Impact in Interim 2026 Financial Materials
2M ago
Chugai Pharmaceutical Delivers Strong First-Half 2026 Results and Confirms Full-Year Outlook
Premium
Company Announcements
Chugai Pharmaceutical Delivers Strong First-Half 2026 Results and Confirms Full-Year Outlook
2M ago
Chugai Confirms H1 2026 Results Included in Roche Group Earnings
Premium
Company Announcements
Chugai Confirms H1 2026 Results Included in Roche Group Earnings
2M ago
CHGCF Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CHGCF Upcoming Earnings Report: What to Expect?
2M ago
Chugai’s Immunotherapy Combo Trial Reaches Completion: What the Latest Update Means for Investors
PremiumCompany Announcements
Chugai’s Immunotherapy Combo Trial Reaches Completion: What the Latest Update Means for Investors
4M ago
CHGCF
Chugai Sets Terms for New Trust-Based Stock Compensation Plans
PremiumCompany Announcements
Chugai Sets Terms for New Trust-Based Stock Compensation Plans
5M ago
Chugai Results Reflected in Roche’s First-Quarter 2026 Sales Report
PremiumCompany Announcements
Chugai Results Reflected in Roche’s First-Quarter 2026 Sales Report
5M ago
CHGCF Earnings this Week: How Will it Perform?
PremiumPre-EarningsCHGCF Earnings this Week: How Will it Perform?
5M ago
Chugai Clarifies Strategic Alliance and Governance Structure Under Roche Control
Premium
Company Announcements
Chugai Clarifies Strategic Alliance and Governance Structure Under Roche Control
6M ago
Chugai Weighs Investment Unit Cut to Boost Liquidity and Broaden Investor Base
Premium
Company Announcements
Chugai Weighs Investment Unit Cut to Boost Liquidity and Broaden Investor Base
6M ago
Chugai, Roche Halt Neuromuscular Trials of Emugrobart but Press On in Obesity
PremiumCompany Announcements
Chugai, Roche Halt Neuromuscular Trials of Emugrobart but Press On in Obesity
6M ago
Chugai and Roche Advance NXT007 Into Phase III, Raising the Stakes in Hemophilia A
PremiumCompany Announcements
Chugai and Roche Advance NXT007 Into Phase III, Raising the Stakes in Hemophilia A
7M ago
CHGCF
Chugai and Roche Advance NXT007 Into Phase III to Challenge Emicizumab in Hemophilia A
PremiumCompany Announcements
Chugai and Roche Advance NXT007 Into Phase III to Challenge Emicizumab in Hemophilia A
7M ago
CHGCF
Chugai’s SAIL66 Phase I Completion: What the Latest Trial Update Means for Investors
PremiumCompany Announcements
Chugai’s SAIL66 Phase I Completion: What the Latest Trial Update Means for Investors
7M ago
CHGCF
Chugai to Replace Restricted Stock with Trust-Based Equity Incentive Plan
PremiumCompany AnnouncementsChugai to Replace Restricted Stock with Trust-Based Equity Incentive Plan
8M ago
Chugai Pharmaceutical Plans Sharp Dividend Hike with 100th Anniversary Payout, Signals Normalization in 2026
Premium
Company Announcements
Chugai Pharmaceutical Plans Sharp Dividend Hike with 100th Anniversary Payout, Signals Normalization in 2026
8M ago
Chugai’s 2025 Performance Reflected in Parent Roche’s Fiscal Results
Premium
Company Announcements
Chugai’s 2025 Performance Reflected in Parent Roche’s Fiscal Results
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >